Novosibirsk State Scientific Center for Virology and Biotechnology "Vector" has launched the second phase of testing a vaccine against coronavirus.

Axar.az reports that the statement came from Anna Popova, head of Russia's Federal Service for Consumer Protection and Welfare (Rospotrebnadzor).

According to him, all the volunteers who took part in the next test phase are feeling well.

"The second phase of clinical trials has begun. No adverse reactions have been observed in the health of vaccinated volunteers. There is not the slightest redness at the injection site," Popova said.

It should be noted that the civilian circulation of the registered vaccine will begin about a month after the third phase of the study.